环球网校是美国纳斯达克上市企业欢聚时代(NASDAQ:YY)旗下品牌 | 住房和城乡建设部 建筑人才培训合作单位
您现在的位置在: > 外语考试 > 英语三级 > 考试资讯 >

维生素D能减轻纤维肌痛患者的疼痛感

2026-10-15 来源:未知 作者:admin
Patients with fibromyalgia syndrome1 (FMS纤维肌痛综合症) typically have widespread chronic2 pain and fatigue3. For those with low vitamin D levels, vitamin D supplements can reduce pain and may be a cost-effective alternative or adjunct(附属的) to other treatment, say researchers in the current issue of PAIN®. In addition to pain and fatigue, individuals diagnosed with FMS may experience sleep disorders4, morning stiffness, poor concentration, and occasionally mild-to-severe mental symptoms such as anxiety or depression. The condition can have a significant impact on the patient's quality of life, resulting in loss of employment and/or withdrawal5 from social life. There is no cure, and no treatment will address all of the symptoms, but some symptoms may be alleviated7 by physical therapy, cognitive8 behavioral therapy, temporary drug therapy (such as amitriptyline, duloxetine, or pregabaline) and multimodal therapies.   Calcifediol (also known as calcidiol, 25-hydroxycholecalciferol, or 25-hydroxyvitamin D (OH)D) is a prehormone produced in the liver by the enzyme9 cholecalciferol (vitamin D3). Calcifediol is then converted to calcitriol (1,25-(OH)2D3), which is the active form of vitamin D. The concentration of calcifediol in blood is considered the best indicator10 of vitamin D status.   Researchers hypothesized that vitamin D supplementation would reduce the degree of chronic pain experienced by FMS patients with low levels of calcifediol and also might improve other symptoms. "Low blood levels of calcifediol are especially common in patients with severe pain and fibromyalgia. But although the role of calcifediol in the perception of chronic pain is a widely discussed subject, we lack clear evidence of the role of vitamin D supplementation in fibromyalgia patients," says lead investigator11 Florian Wepner, MD, of the Department of Orthopaedic Pain Management, Spine12 Unit, Orthopaedic Hospital, Speising, Vienna, Austria. "We therefore set out to determine whether raising the calcifediol levels in these patients would alleviate6 pain and cause a general improvement in concomitant(相伴的) disorders."

责编:admin 返回顶部  打印

关于我们 ┊ 联系我们 ┊ 友情链接 ┊ 网站声明 ┊ 网站地图 ┊ 广告服务 ┊ ┊ 帮助中心